Microfluidic Solutions for Vaccines & Gene Therapy
Optimizing mRNA, LNP, and Gene Delivery at Scale
NanoSynthes empowers the production of mRNA vaccines, lipid nanoparticles (LNPs), and gene therapies through advanced microfluidic technology—ensuring clinical-grade precision, high encapsulation efficiency, and reliable scalability from R&D to GMP-compliant manufacturing.
Why Microfluidics for Vaccine & Gene Therapy?
Efficient LNP & Nanocarrier Formation
Precise lipid mixing ensures optimal particle size & encapsulation efficiency.
Scalable from R&D to GMP Manufacturing
Seamless scale-up with controlled batch-to-batch reproducibility.
High Drug Encapsulation Efficiency
Improves payload protection & delivery for mRNA, siRNA, and gene therapies.
Regulatory-Ready Nanoparticle Production
Meets pharmaceutical-grade production standards with GMP compliance.
Applications in Vaccines & Gene Therapy
NanoSynthes ensures that mRNA and gene-based therapies achieve high reproducibility, efficiency, and clinical scalability, eliminating bottlenecks in biopharma production.
mRNA & DNA Vaccines
Gene Therapy Delivery
LNP-Encapsulated Biologics
Commercial Biopharma Manufacturing
Why Pharma Leaders Choose NanoSynthes?

Industry-Proven Technology
Trusted in LNP-based vaccine manufacturing.
GMP-Ready, Scalable Solutions
From small batches to high-volume production.
Minimize degradation, maximize bioavailability.
Reduced waste & optimized resource usage
Expert Bioprocess Support
End-to-end consultation from R&D to full-scale commercialization.
